APA (7th ed.) Citation

O'Brien, S. G., Meinhardt, P., Bond, E., Beck, J., Peng, B., Dutreix, C., . . . Fischer, T. (2003). Effects of imatinib mesylate (STI571, Glivec) on the pharmacokinetics of simvastatin, a cytochrome p450 3A4 substrate, in patients with chronic myeloid leukaemia. British Journal of Cancer, 89(10), 1855. https://doi.org/10.1038/sj.bjc.6601152

Chicago Style (17th ed.) Citation

O'Brien, S. G., et al. "Effects of Imatinib Mesylate (STI571, Glivec) on the Pharmacokinetics of Simvastatin, a Cytochrome P450 3A4 Substrate, in Patients with Chronic Myeloid Leukaemia." British Journal of Cancer 89, no. 10 (2003): 1855. https://doi.org/10.1038/sj.bjc.6601152.

MLA (9th ed.) Citation

O'Brien, S. G., et al. "Effects of Imatinib Mesylate (STI571, Glivec) on the Pharmacokinetics of Simvastatin, a Cytochrome P450 3A4 Substrate, in Patients with Chronic Myeloid Leukaemia." British Journal of Cancer, vol. 89, no. 10, 2003, p. 1855, https://doi.org/10.1038/sj.bjc.6601152.